Conversely, miR-744 increased the risk of pancreatic cancer, prostate cancer and nasopharyngeal carcinoma by activating the Wnt/β-catenin pathway, AMPK signaling, and transcriptional regulation of ARHGAP5, respectively (Zhou et al., 2015; Zhang et al., 2019). The gene discussed is ARHGAP5; the disease is prostate carcinoma.